Determining whether CD38 regulates intracellular NAD+ level is functionally important because if confirmed, a cell-autonomous mechanism of CD38 loss, rather than a function mediated through the tumor microenvironment, may be inferred. The gene discussed is CD38; the disease is neoplasm.